Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Bais, Aagje G ^a   Beckmann, Ilse ^a   Ewing, Patricia C ^a   Eijkemans, Marinus J C ^a   Meijer, Chris J L M ^b   Snijders, Peter J F ^b   Helmerhorst, Theo J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; BLOOD CULTURE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS; BIOLOGICAL MODEL; CARCINOMA; CASE CONTROL STUDY; KINETICS; METABOLISM; MONONUCLEAR CELL; PAPILLOMA VIRUS; STATISTICAL MODEL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KINETICS; LEUKOCYTES, MONONUCLEAR; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PAPILLOMAVIRIDAE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 38749134874     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/24147     Document Type: Article

References (29)

1. S. K. Kjaer B. Chackerian A. J. C. van den Brule High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiology Biomarkers & Prevention 10 2 2001 101 106
2. J. M. M. Walboomers JMM.Walboomers@azvu.nl M. V. Jacobs M. M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 189 1 1999 12 19
3. T. J. M. Helmerhorst helmerhorst@gyna.azr.nl C. J. L. M. Meijer Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. International Journal of Gynecological Cancer 12 3 2002 235 236
4. N. Mũoz cris@ico.scs.es F. X. Bosch S. de Sanjosé Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 348 6 2003 518 527
5. A.-B. Moscicki annam@itsa.ucsf.edu J. H. Ellenberg S. Farhat J. Xu Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescentgirls: risk factors and differences, by phylogenetic type. Journal of Infectious Diseases 190 1 2004 37 45
6. M. A. E. Nobbenhuis J. M. M. Walboomers T. J. M. Helmerhorst Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening:a prospective study. The Lancet 354 9172 1999 20 25
7. T.-C. Wu R. J. Kurman Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. Journal of the National Cancer Institute 89 3 1997 185 187
8. B. Spellberg J. E. Edwards Jr. Type 1/type 2 immunity in infectious diseases. Clinical Infectious Diseases 32 1 2001 76 102
9. M. Clerici G. M. Shearer E. Clerici Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. Journal of the National Cancer Institute 90 4 1998 261 263
10. T. Tsukui A. Hildesheim M. H. Schiffman Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides:correlation with cervical pathology. Cancer Research 56 17 1996 3967 3974
11. M. Clerici M. Merola E. Ferrario Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. Journal of the National Cancer Institute 89 3 1997 245 250
12. A. de Jong M. I. E. van Poelgeest J. M. van der Hulst Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity againstearly antigens E2 and E6. Cancer Research 64 15 2004 5449 5455
13. H. J. Bontkes T. D. de Gruijl A. Bijl Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. Journal of General Virology 80 9 1999 2453 2459
14. B.-N. Lee blee@mdanderson.org M. Follen D.-Y. Shen Depressed type 1 cytokine synthesis by superantigen-sctivated CD4+ T cells of women withhuman papillomavirus-related high-grade squamous intraepithelial lesions. Clinical and Diagnostic Laboratory Immunology 11 2 2004 239 244
15. J. C. Steele C. H. Mann S. Rookes T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. British Journal of Cancer 93 2005 248 259
16. D. E. Warrino W. C. Olson W. T. Knapp Disease-stage variance in functional CD4+ T-cell responses against novel pan-human leukocyteantigen-D region presented human papillomavirus-16 E7 epitopes. Clinical Cancer Research 10 10 2004 3301 3308
17. N. Jacobs S. L. Giannini J. Doyen Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clinical & Experimental Immunology 111 1 1998 219 224
18. H. Mori T. Hanabayashi Y. Yamada T. Tamaya Decrease in interferon-γ production by peripheral blood mononuclear cells in patients with uterine cervical cancer. Journal of Clinical Immunology 10 1 1990 45 51
19. M. Scott M. Nakagawa A.-B. Moscicki Cell-mediated immune response to human papillomavirus infection. Clinical and Diagnostic Laboratory Immunology 8 2 2001 209 220
20. A. G. Bais I. Beckmann J. Lindemans A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. Journal of Clinical Pathology 58 10 2005 1096 1100
21. A. J. C. van den Brule R. Pol N. Fransen-Daalmeijer L. M. Schouls C. J. L. M. Meijer P. J. F. Snijders GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. Journal of Clinical Microbiology 40 3 2002 779 787
22. M. V. Jacobs P. J. F. Snijders A. J. C. van den Brule T. J. M. Helmerhorst C. J. L. M. Meijer J. M. M. Walboomers A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. Journal of Clinical Microbiology 35 3 1997 791 795
23. D. de Groote P. F. Zangerle Y. Gevaert Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in wholeblood. I. Comparison with isolated PBMC stimulation. Cytokine 4 3 1992 239 248
24. A. M. Saunders Sources of physiological variation in differential leukocyte counting. Blood Cells 11 1 1985 31 48
25. S. McHugh J. Deighton I. Rifkin P. Ewan Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheralblood mononuclear cells in primary culture. European Journal of Immunology 26 6 1996 1260 1265
26. A.-B. Moscicki annam@itsa.ucsf.edu J. H. Ellenberg P. Crowley-Nowick T. M. Darragh J. Xu S. Fahrat Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents. Journal of Infectious Diseases 190 8 2004 1413 1421
27. H.-C. Lai C.-C. Chang Y.-W. Lin Genetic polymorphism of the interferon-γ gene in cervical carcinogenesis. International Journal of Cancer 113 5 2005 712 718
28. D. C. Henderson J. J. Rippin Stimulus-dependent production of cytokines and pterins by peripheral blood mononuclear cells. Immunology Letters 45 1-2 1995 29 34
29. A. G. Östor Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecological Pathology 12 2 1993 186 192